Dublin-based clinical research group Icon has purchased a 70 per cent stake in an American medical imaging firm for just under $10 million.
Icon bought the stake in clinical research organisation Beacon Bioscience, which specialises in processing and reading of digital images from many clinical tests including X-rays, MRIs, and ultrasound scans.
The cash consideration is 9.9 million and this includes an investment in new equity of $2 million.